Integra LifeSciences IART Total costs & expenses
Total costs & expenses at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Integra LifeSciences in its filing.
Tagged under the XBRL concept us-gaap:CostsAndExpenses.
The official record: Integra LifeSciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Integra LifeSciences's total costs & expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Integra LifeSciences's total costs & expenses?
- Integra LifeSciences (IART) reported total costs & expenses of $380.45M in Q1 2026.
- How has Integra LifeSciences's total costs & expenses changed year-over-year?
- Integra LifeSciences's total costs & expenses decreased by 4.4% year-over-year, from $398.15M to $380.45M.
- What is the long-term trend for Integra LifeSciences's total costs & expenses?
- Over 4 years (2021 to 2025), Integra LifeSciences's total costs & expenses has grown at a 12.2% compound annual growth rate (CAGR), from $1.35B to $2.13B.
- What does total costs & expenses mean?
- This metric represents the aggregate sum of all operating and non-operating costs incurred by the company to generate revenue and maintain business operations. It encompasses cost of goods sold, research and development, selling, general and administrative expenses, as well as any asset impairments or restructuring charges. Monitoring this figure provides insight into the company's overall cost structure and its ability to manage expenditures relative to its top-line performance.